Daily Financial Update
Opening Recap
Market Pulse: Bulls cheered as whispers of a Rio Tinto–Glencore tie-up keep commodity indices on edge, while biotech shocks rippled through healthcare sectors.
Key Movers: Talk of an all-star mining merger drove chatter in London and Sydney, while Corcept Therapeutics’ FDA setback sent small biotechs into a tailspin.
Macro & Politics: Veterans’ underground psychedelic clinics highlight cracks in the VA system, and silver speculators vow to rattle banking halls.
What’s Next: Eyes on CEO succession news from Rio and any new FDA guidance on relacorilant before the opening bell.
Market Commentary
What everyone’s missing is how a pending Rio-Glencore tie-up, as detailed in “Rio-Glencore Deal Closer Than Ever With Premium and CEO in Focus” (Financial Post), could flood raw materials and undercut pricing power, yet most traders are asleep at the wheel. This move might deliver a hell of a blow to current commodity rallies if boards can’t nail down leadership fast. Don’t sleep on the supply-side shock.
Pairing Corcept Therapeutics’ crushing FDA complete response letter (“Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman” – GlobeNewswire) with the fervor of retail silver brawlers in “Silver Stackers Aim to ‘Screw the Bankers’” (Dailyreckoning.com) reveals a deeper market frustration. Investors dumped small-cap biotech over regulatory blind spots, then piled into precious metals to thumb their noses at big finance. This unplugged mindset could spark unpredictable cross-asset ripples, so brace for contagion.
If you haven’t positioned for these dislocations, start looking at diversified commodity plays and small-caps with clear catalyst risks. Hedge against regulatory black swans in biotech, while keeping an eye on short-squeeze setups in metals. It’s time to pick sides—fear or opportunity—before the next headline lands.
📈 Breaking Financial News
Silver Stackers Aim to ‘Screw the Bankers’
This post Silver Stackers Aim to ‘Screw the Bankers’ appeared first on Daily Reckoning. The short squeeze narrative in silver is STRONG. The post Silver Stackers Aim to ‘Screw the Bankers’ appeared first on Daily Reckoning.
MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026….
GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained
GLP-1 Booster from Health Journey examined: Akkermansia, Clostridium butyricum, gut microbiome probiotic research and metabolic science for 2026….
Best Berberine Patch for Transdermal Metabolic Support: NuraPatch Cited in Industry Analysis as Consumer Interest in Botanical Weight Management Options Grows
Best berberine patch category examined: NuraPatch cited as consumer interest in transdermal botanical metabolic support options grows into 2026….
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
– Rapidly transforming into a leading global biopharma company – Rapidly transforming into a leading global biopharma company
Sell Nvidia and replace it with WHAT?!
The truth behind Eric Fry's off-the-wall trade idea… Eric Fry is breaking ranks with Wall Street by saying “Sell Nvidia.” Because history, he says, is repeating itself. In 2000, Eric Fry told Barron's that folks should sell one of the dot-com boom's most beloved stocks right before it fell more than 90%. Now, he says investors need to replace Nvidia stock with a much better alternative – before their money is wiped out. Get the details here – including free tickers and analysis
🔍 Market Analysis & Insights
Rio-Glencore Deal Closer Than Ever With Premium and CEO in Focus
Glencore Plc boss Gary Nagle has called it the most obvious deal in mining. His predecessor and mentor Ivan Glasenberg has been trying to pull it off for nearly two decades. And yet the merger of Glencore with Rio Tinto Group has proven elusive – until now.
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman
SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter (“CRL”) from the…
PIPPIN – Up 46% in a day, will it finally re-capture its lost levels?
PIPPIN's trajectory could be shaped in the next few sessions.
Report: GameStop closing hundreds of stores in the United States
The news comes as the firm puts CEO Ryan Cohen on track for $35m payday if he can increase its market cap by 950%
Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034
The pulse oximeter market size is set to expand from USD 3.56 billion in 2024 to USD 6.76 billion by 2034, with a CAGR of 6.64%….
History-Making Stocks Rarely Make Headlines.
While Nvidia makes all the headlines, this little-known company is already beginning to surpass Nvidia's stock gains this year as data center growth surges. I believe this stock could soar in the next 12-24 months, potentially leaving Nvidia in the dust. I want to give you the name, ticker and my full analysis today – because I know you certainly won't hear about this stock in the mainstream financial media. Click here to get all the details…
💰 Investment Opportunities
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of…
Clene Announces Registered Direct Offering of Over $28 Million
SALT LAKE CITY, Jan. 09, 2026 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused on revolutio…
Regulating Human Health Beverage Industry 4.0 Adoption Status
Download Sample Get Special Discount Regulating Human Health Beverage Market Global Outlook, Country Deep-Dives & Strategic Opportunities (2024-2033) Market size (2024): USD 15.2 billion · Forecast (2033): 27.
For Some Veterans, Psychedelics Are a Last Hope—and a Dangerous Gamble
This story was supported by the Pulitzer Center. It first appeared on The War Horse, an award-winning nonprofit news organization educating the public on military service. Subscribe to their newsletter. Marc Dervaes sat straight-backed in a circle of 10 men a…
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.